Ashima Gulati1, Alok Sharma2, Pankaj Hari1, Amit K Dinda2, Arvind Bagga3. 1. Department of Pediatrics, All India Institute of Medical Sciences, Teaching block, Room number 3053#, Ansari Nagar, New Delhi, 110029, India. 2. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. 3. Department of Pediatrics, All India Institute of Medical Sciences, Teaching block, Room number 3053#, Ansari Nagar, New Delhi, 110029, India. arvindbagga@hotmail.com.
Abstract
BACKGROUND: Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis (FSGS). Pathologically similar lesions have been reported in adults and children with human immuno-deficiency virus (HIV) infection. However, there is a recent interest in the recognition of this variant in the absence of HIV infection. AIM: To evaluate the clinical presentation and outcome of our pediatric patients with idiopathic CG. METHODS: A sum of six children with idiopathic CG, aged 1-7 years at presentation, were retrospectively identified. Clinical data and renal biopsy were reviewed for all patients. Serum creatinine and estimated GFRs at presentation and last follow-up were compared using the Wilcoxon signed rank test and the risk factors for occurrence of ESRD analyzed using the Cox proportional hazard models. RESULTS: Steroid-resistant nephrotic syndrome with or without azotemia was the presenting clinical finding in all the cases. The median serum creatinine values at onset and last follow-up were 1.05 and 1.25 mg/dl, respectively (p = 0.128). Following immunosuppressive therapy one patient achieved complete remission of proteinuria, and four were in partial remission. The remaining one patient did not show any change in proteinuria at 6 months of therapy. Two of the six patients progressed to end-stage renal disease within a median follow-up period of 27 months (range 14-96 months). CONCLUSIONS: Collapsing glomerulopathy is an aggressive variant of focal segmental glomerulosclerosis. All patients with CG should be screened for the underlying etiology, and patients with idiopathic CG should be offered a trial of immunosuppressive therapy.
BACKGROUND:Collapsing glomerulopathy (CG) is a clinically and pathologically distinct variant of focal segmental glomerulosclerosis (FSGS). Pathologically similar lesions have been reported in adults and children with humanimmuno-deficiency virus (HIV) infection. However, there is a recent interest in the recognition of this variant in the absence of HIV infection. AIM: To evaluate the clinical presentation and outcome of our pediatric patients with idiopathic CG. METHODS: A sum of six children with idiopathic CG, aged 1-7 years at presentation, were retrospectively identified. Clinical data and renal biopsy were reviewed for all patients. Serum creatinine and estimated GFRs at presentation and last follow-up were compared using the Wilcoxon signed rank test and the risk factors for occurrence of ESRD analyzed using the Cox proportional hazard models. RESULTS:Steroid-resistant nephrotic syndrome with or without azotemia was the presenting clinical finding in all the cases. The median serum creatinine values at onset and last follow-up were 1.05 and 1.25 mg/dl, respectively (p = 0.128). Following immunosuppressive therapy one patient achieved complete remission of proteinuria, and four were in partial remission. The remaining one patient did not show any change in proteinuria at 6 months of therapy. Two of the six patients progressed to end-stage renal disease within a median follow-up period of 27 months (range 14-96 months). CONCLUSIONS:Collapsing glomerulopathy is an aggressive variant of focal segmental glomerulosclerosis. All patients with CG should be screened for the underlying etiology, and patients with idiopathic CG should be offered a trial of immunosuppressive therapy.
Authors: Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt Journal: Clin Chem Date: 2005-12-06 Impact factor: 8.327
Authors: D C Cattran; E Alexopoulos; P Heering; P F Hoyer; A Johnston; A Meyrier; C Ponticelli; T Saito; G Choukroun; P Nachman; M Praga; N Yoshikawa Journal: Kidney Int Date: 2007-09-26 Impact factor: 10.612
Authors: Gurinder Kumar; Rajendran Nair; Bassem Soliman Hendawy; Omar Ahmed AlShkeili; Ahmed Abdulla Alabdouli; Adnan Mohamed Al Ali; Amal Mohamed Jasem AlTenaiji Journal: CEN Case Rep Date: 2019-02-12
Authors: Kamal V Kanodia; Aruna V Vanikar; Rashmi D Patel; Kamlesh S Suthar; Lovelesh K Nigam; Himanshu V Patel; Vivek Kute; Hargovind L Trivedi Journal: J Clin Diagn Res Date: 2016-04-01